Tools
ToolsClement, Naomi S., Abul, Ahmad, Farrelly, Rachel, Murphy, Helen R., Forbes, Karen, Simpson, Nigel A. B. and Scott, Eleanor M. (2024) Pregnancy outcomes in type 2 diabetes: A systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. ISSN 0002-9378
Preview |
PDF (Clement_etal_2025_AJOG)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (1MB) | Preview |
Abstract
Objective: Type 2 diabetes (T2D) now accounts for the majority of pre-existing diabetes affecting pregnancy in the UK. Our aim was to determine its impact on pregnancy outcomes compared to type 1 diabetes (T1D), gestational diabetes (GDM), and nondiabetes pregnancies. Data Sources: PubMed was searched 1 January 2009 to 2024. Study Eligibility Criteria: Cohort observational studies reporting original data on at least one of the primary outcomes in ten or more T2D pregnancies were eligible for inclusion. Comparative diabetes and nondiabetes pregnancies were also collected. Methods: Primary outcomes included congenital anomalies, stillbirths, neonatal and perinatal mortality, birthweight, rates of large for gestational age (LGA), small for gestational age (SGA), and macrosomia. PROSPERO ID CRD42023411057. Results: Forty seven studies were analyzed. The number of pregnancies in each analysis varied depending on the available data from the outcome being analyzed but ranged from 723 to 4,469,053 pregnancies. When compared with T1D pregnancies, T2D were more likely to have SGA babies as well as greater neonatal and perinatal mortality (OR 2.29, 95% CI 1.12–4.67; OR 1.53 95% CI 1.20–1.94, and OR 1.31 95% CI 1.07–1.61, respectively). When compared with GDM, T2D were more likely to have babies with congenital anomalies (OR 1.91, 95% CI 1.04–3.50), LGA (OR 3.49, 95% CI 2.49–4.89), neonatal mortality (OR 3.96, 95% CI 3.38–4.64), and stillbirth (OR 16.55, 95% CI 5.69–48.11). In comparison to nondiabetic pregnancy, T2D were more likely to have babies with congenital anomalies (OR 1.76, 95% CI 1.11–2.79), LGA (OR 2.79, 95% CI 1.93–4.04), perinatal mortality (OR 4.18, 95% CI 2.91–6.01), and stillbirth (OR 7.27, 95% CI 3.01–17.53). Conclusion: T2D pregnancies are associated with a greater perinatal mortality than other forms of diabetes in pregnancy. Given its increasing prevenance, greater awareness of the adverse pregnancy outcomes associated with T2D is needed, by both healthcare providers and policy makers, to improve care.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | congenital malformations,diabetes in pregnancy,perinatal mortality,pregnancy outcomes,stillbirth,type 2 diabetes,obstetrics and gynaecology,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2729 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 13 Dec 2024 01:39 |
| Last Modified: | 19 Feb 2025 17:30 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/97988 |
| DOI: | 10.1016/j.ajog.2024.11.026 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |